As of January 2025 Neurocrine Biosciences has a market cap of ₹1.287 Trillion. This makes Neurocrine Biosciences the world's 1224th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jan 21st, 2025 the market cap of Neurocrine Biosciences was reported to be: